KORU Medical (KRMD) Fundamental Analysis: Revenue, Earnings & Valuation

0.50 / 10

Underperform

Fundamentals are rated Underperform with a 0.5/10 score. Revenue‑MV and Cash‑MV are negative, while Profit‑MV shows modest strength. Overall fund score is 0.5, indicating weak financial health despite slight profit‑margin upside.

Analysis Checks(4/10)

Revenue-MV

Value-1.46

Score0/3

Weight53.88%

1M Return-4.18%

ROA (%)

Value-9.52

Score1/3

Weight11.23%

1M Return-0.82%

Net cash flow from operating activities / Operating revenue (%)

Value1.12

Score2/3

Weight-23.57%

1M Return1.48%

Profit-MV

Value0.66

Score2/3

Weight-50.89%

1M Return3.09%

Annualized net profit margin on total assets (%)

Value-9.52

Score1/3

Weight11.23%

1M Return-0.82%

EBIT / Total operating revenue (%)

Value-7.07

Score2/3

Weight-1.52%

1M Return0.10%

Asset-MV

Value-0.55

Score0/3

Weight44.27%

1M Return-3.44%

Net profit / Total operating revenue (%)

Value-6.41

Score3/3

Weight-22.66%

1M Return1.41%

Cash-MV

Value-2.31

Score1/3

Weight48.24%

1M Return-4.16%

Net profit / Total profit (%)

Value100.84

Score1/3

Weight29.79%

1M Return-2.39%

Is KRMD fundamentally strong?

KRMD scores 0.50/10 on fundamentals and holds a Premium valuation at present. Backed by its -15.58% ROE, -6.41% net margin, -75.06 P/E ratio, 11.61 P/B ratio, and 53.85% earnings growth, these metrics solidify its Underperform investment rating.